Darrin Miles
Chief Executive Officer at Nested Therapeutics, Inc.
Profile
Darrin Miles is currently the Chief Executive Officer & Director at Nested Therapeutics, Inc. Prior to this, he worked as the Chief Commercial Officer at Agios Pharmaceuticals, Inc. from 2015 to 2021.
He completed his undergraduate degree at Cornell University.
Darrin Miles active positions
| Companies | Position | Start |
|---|---|---|
Nested Therapeutics, Inc.
 Nested Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nested Therapeutics, Inc. is a biotechnology company based in Cambridge, MA. The company focuses on discovering and developing novel, targeted, small molecule precision medicine therapies for cancer patients. The company uses mutation clusters to identify druggable pockets and have a platform that utilizes insights from genomics, computational chemistry, proteomics, and AI. Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations to reach a broader group of patients. The company was founded by Arvin Dar and Klaus Hoeflich. The CEO is Darrin Miles. | Chief Executive Officer | - |
Former positions of Darrin Miles
| Companies | Position | End |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2021-12-05 |
Training of Darrin Miles
| Cornell University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Nested Therapeutics, Inc.
Nested Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nested Therapeutics, Inc. is a biotechnology company based in Cambridge, MA. The company focuses on discovering and developing novel, targeted, small molecule precision medicine therapies for cancer patients. The company uses mutation clusters to identify druggable pockets and have a platform that utilizes insights from genomics, computational chemistry, proteomics, and AI. Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations to reach a broader group of patients. The company was founded by Arvin Dar and Klaus Hoeflich. The CEO is Darrin Miles. | Commercial Services |
- Stock Market
- Insiders
- Darrin Miles
